On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Francesco Facchinetti

ResearcherPublications, citations & collaboration network

Francesco Facchinetti is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Francesco Facchinetti have?

ScholarIQindexed works

Francesco Facchinetti has 319 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Francesco Facchinetti have?

ScholarIQcitation count

Francesco Facchinetti has 4,030 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Francesco Facchinetti?

ScholarIQh-index

Francesco Facchinetti has an h-index of 35 in OpenAlex.

What is the i10-index of Francesco Facchinetti?

ScholarIQi10-index

Francesco Facchinetti has an i10-index of 73 in OpenAlex.

What is the ORCID of Francesco Facchinetti?

ScholarIQorcid

The ORCID for Francesco Facchinetti is on the source record.

What is the OpenAlex record for Francesco Facchinetti?

ScholarIQopenalex

The OpenAlex for Francesco Facchinetti is on the source record.

What are the most-cited papers on Francesco Facchinetti?

ScholarIQmost cited works
Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?
Gonzalo Recondo, Francesco Facchinetti, Ken A. Olaussen, Benjamin Besse, Luc Friboulet
Nature Reviews Clinical Oncology. 2018331 Citations
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti, David Planchard, Anas Gazzah, Ludovic Bigot, Ahsan Z. Rizvi, Rosa L. Frias, Jean Paul Thiery, Jean‐Yves Scoazec, Tony Sourisseau, Karen Howarth, Olivier Déas, Dariia Samofalova, Justine Galissant, Pauline Tesson, Floriane Brayé, Charles Naltet, Pernelle Lavaud, Linda Mahjoubi, Aurélie Abou Lovergne, Gilles Vassal, Rastilav Bahleda, Antoine Hollebecque, Claudio Nicotra, Maud Ngo‐Camus, Stefan Michiels, Ludovic Lacroix, Catherine Richon, Nathalie Auger, Thierry de Baère, Lambros Tselikas, Éric Solary, Eric Angevin, Alexander Eggermont, Fabrice André, Christophe Massard, Ken A. Olaussen, Jean‐Charles Soria, Benjamin Besse, Luc Friboulet
Clinical Cancer Research. 2019169 CitationsOPEN ACCESS
BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall
Alessandro Leonetti, Francesco Facchinetti, Giulio Rossi, Roberta Minari, Antonia Conti, Luc Friboulet, Marcello Tiseo, David Planchard
Cancer Treatment Reviews. 2018167 Citations
Transferrin receptor targeting chimeras for membrane protein degradation
Dingpeng Zhang, Jhoely Duque-Jimenez, Francesco Facchinetti, Garyk Brixi, Kaitlin Rhee, William W. Feng, Pasi A. Jänne, Xin Zhou
Nature. 2024159 CitationsOPEN ACCESS
Crizotinib-Resistant <i>ROS1</i> Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for <i>ROS1</i> - and <i>ALK</i> -Rearranged Lung Cancers
Francesco Facchinetti, Yohann Loriot, Mei-Shiue Kuo, Linda Mahjoubi, Ludovic Lacroix, David Planchard, Benjamin Besse, Françoise Farace, Nathalie Auger, Jordi Remón, Jean‐Yves Scoazec, Fabrice André, Jean‐Charles Soria, Luc Friboulet
Clinical Cancer Research. 2016151 Citations

Related on ScholarIQ

470M+ articles · 14-day free trial